Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Rectal cancer
#NCT05723562
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
MSS
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), CHU de Rennes - Hôpital Pontchaillou (Rennes), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Hôpital Larrey (Toulouse ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Tenon AP-HP (Paris ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre François Baclesse (Caen ) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Prostate cancer
#NCT05849298
Metastatic Castration-resistant
Immunotherapy
Internal Vectorised Radiotherapy (IVR)
PSMA PET Positive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Hôpital Cochin (Paris ), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), CHU Caen Normandie (Caen)
Novartis
Phase 2
Lung cancer
#NCT05403385
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
EGFR
ALK
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Léon Bérard (Lyon), Hôpital de la Timone AP-HM (Marseille) (and 4 more...)
iTeos Belgique SA
Phase 2
Lung cancer
#NCT05325866
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen
Phase 2
Breast cancer
#NCT05325866
HER2 Negative
HR Negative
Locally Advanced
Metastatic
FGFR
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Oscar Lambret (Lille), Institut Paoli-Calmettes (Marseille), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 2 more...)
Amgen
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05118789
SCLC (Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
Metastatic Castration-resistant
ROS-1
Other mutation
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Targeted therapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Chemotherapy
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.